- ¥138bn
- ¥128bn
- ¥40bn
Table: Takara Bio -Q1 group results
Brief: Takara Bio completes share repurchase
Brief: Wafergen Bio-Systems and Takara Bio signs distribution agreement for Japan
Brief: Wafergen to pay Takara Bio USA Holdings termination fee equal to $2 mln
Brief: Takara Bio unit to fully acquire WaferGen Bio-systems
Table: Takara Bio -2015/16 group results
Table: Takara Bio -2015/16 parent results
Brief: Molmed agrees with Takara Bio on discontinuing their collaboration on TK (Zalmoxis)
Table: Takara Bio -9-MTH group results
Table: Takara Bio -6-MTH group results
Table: Takara Bio Inc. -2015 6-month group forecast